nodes	percent_of_prediction	percent_of_DWPC	metapath
Betamethasone—ankylosing spondylitis—osteoporosis	0.316	1	CtDrD
Betamethasone—CYP19A1—osteoporosis	0.157	1	CbGaD
Betamethasone—breast cancer—Conjugated Estrogens—osteoporosis	0.106	0.363	CpDpCtD
Betamethasone—breast cancer—Estradiol—osteoporosis	0.106	0.363	CpDpCtD
Betamethasone—breast cancer—Ethinyl Estradiol—osteoporosis	0.0801	0.275	CpDpCtD
Betamethasone—PTGS2—Risedronate—osteoporosis	0.048	0.334	CbGbCtD
Betamethasone—CYP19A1—Raloxifene—osteoporosis	0.0378	0.263	CbGbCtD
Betamethasone—ABCB1—Ethinyl Estradiol—osteoporosis	0.00773	0.0537	CbGbCtD
Betamethasone—CYP3A4—Estropipate—osteoporosis	0.00718	0.05	CbGbCtD
Betamethasone—CYP3A4—Calcitriol—osteoporosis	0.00718	0.05	CbGbCtD
Betamethasone—CYP3A4—Ergocalciferol—osteoporosis	0.00574	0.0399	CbGbCtD
Betamethasone—ABCB1—Conjugated Estrogens—osteoporosis	0.00567	0.0394	CbGbCtD
Betamethasone—ABCB1—Estradiol—osteoporosis	0.00498	0.0346	CbGbCtD
Betamethasone—CYP3A4—Raloxifene—osteoporosis	0.00479	0.0333	CbGbCtD
Betamethasone—CYP3A4—Ethinyl Estradiol—osteoporosis	0.00463	0.0322	CbGbCtD
Betamethasone—CYP3A4—Cholecalciferol—osteoporosis	0.0037	0.0257	CbGbCtD
Betamethasone—CYP3A4—Conjugated Estrogens—osteoporosis	0.0034	0.0236	CbGbCtD
Betamethasone—CYP3A4—Estradiol—osteoporosis	0.00298	0.0207	CbGbCtD
Betamethasone—Testolactone—CYP19A1—osteoporosis	0.000237	0.358	CrCbGaD
Betamethasone—Fluoxymesterone—SHBG—osteoporosis	0.000163	0.246	CrCbGaD
Betamethasone—Fluoxymesterone—ESR1—osteoporosis	0.00011	0.166	CrCbGaD
Betamethasone—Hydrocortisone—SHBG—osteoporosis	9.9e-05	0.149	CrCbGaD
Betamethasone—Dexamethasone—CYP19A1—osteoporosis	5.42e-05	0.0817	CrCbGaD
Betamethasone—Nervous system disorder—Risedronate—osteoporosis	4.73e-05	0.000676	CcSEcCtD
Betamethasone—Discomfort—Pamidronate—osteoporosis	4.73e-05	0.000675	CcSEcCtD
Betamethasone—Angioedema—Zoledronate—osteoporosis	4.69e-05	0.00067	CcSEcCtD
Betamethasone—Gastrointestinal pain—Calcitriol—osteoporosis	4.69e-05	0.00067	CcSEcCtD
Betamethasone—Abdominal pain—Raloxifene—osteoporosis	4.68e-05	0.000668	CcSEcCtD
Betamethasone—Body temperature increased—Raloxifene—osteoporosis	4.68e-05	0.000668	CcSEcCtD
Betamethasone—Urticaria—Ibandronate—osteoporosis	4.65e-05	0.000664	CcSEcCtD
Betamethasone—Malaise—Zoledronate—osteoporosis	4.63e-05	0.000661	CcSEcCtD
Betamethasone—Body temperature increased—Ibandronate—osteoporosis	4.63e-05	0.000661	CcSEcCtD
Betamethasone—Abdominal pain—Ibandronate—osteoporosis	4.63e-05	0.000661	CcSEcCtD
Betamethasone—Vertigo—Zoledronate—osteoporosis	4.61e-05	0.000659	CcSEcCtD
Betamethasone—Syncope—Zoledronate—osteoporosis	4.6e-05	0.000658	CcSEcCtD
Betamethasone—Anaphylactic shock—Pamidronate—osteoporosis	4.59e-05	0.000655	CcSEcCtD
Betamethasone—Oedema—Pamidronate—osteoporosis	4.59e-05	0.000655	CcSEcCtD
Betamethasone—Haemoglobin—Estradiol—osteoporosis	4.57e-05	0.000653	CcSEcCtD
Betamethasone—Infection—Pamidronate—osteoporosis	4.56e-05	0.000651	CcSEcCtD
Betamethasone—Urticaria—Calcitriol—osteoporosis	4.55e-05	0.00065	CcSEcCtD
Betamethasone—Haemorrhage—Estradiol—osteoporosis	4.55e-05	0.000649	CcSEcCtD
Betamethasone—Abdominal pain—Calcitriol—osteoporosis	4.53e-05	0.000647	CcSEcCtD
Betamethasone—Body temperature increased—Calcitriol—osteoporosis	4.53e-05	0.000647	CcSEcCtD
Betamethasone—Angioedema—Conjugated Estrogens—osteoporosis	4.52e-05	0.000645	CcSEcCtD
Betamethasone—Shock—Pamidronate—osteoporosis	4.51e-05	0.000645	CcSEcCtD
Betamethasone—Loss of consciousness—Zoledronate—osteoporosis	4.51e-05	0.000645	CcSEcCtD
Betamethasone—Nervous system disorder—Pamidronate—osteoporosis	4.5e-05	0.000643	CcSEcCtD
Betamethasone—Thrombocytopenia—Pamidronate—osteoporosis	4.49e-05	0.000642	CcSEcCtD
Betamethasone—Vomiting—Etidronic acid—osteoporosis	4.49e-05	0.000641	CcSEcCtD
Betamethasone—Tachycardia—Pamidronate—osteoporosis	4.48e-05	0.00064	CcSEcCtD
Betamethasone—Rash—Etidronic acid—osteoporosis	4.45e-05	0.000636	CcSEcCtD
Betamethasone—Convulsion—Zoledronate—osteoporosis	4.45e-05	0.000635	CcSEcCtD
Betamethasone—Dermatitis—Etidronic acid—osteoporosis	4.45e-05	0.000635	CcSEcCtD
Betamethasone—Vertigo—Conjugated Estrogens—osteoporosis	4.44e-05	0.000634	CcSEcCtD
Betamethasone—Hyperhidrosis—Pamidronate—osteoporosis	4.43e-05	0.000633	CcSEcCtD
Betamethasone—Syncope—Conjugated Estrogens—osteoporosis	4.43e-05	0.000633	CcSEcCtD
Betamethasone—Hypertension—Zoledronate—osteoporosis	4.43e-05	0.000633	CcSEcCtD
Betamethasone—Headache—Etidronic acid—osteoporosis	4.42e-05	0.000632	CcSEcCtD
Betamethasone—Musculoskeletal discomfort—Risedronate—osteoporosis	4.4e-05	0.000628	CcSEcCtD
Betamethasone—Asthenia—Estropipate—osteoporosis	4.38e-05	0.000626	CcSEcCtD
Betamethasone—Visual impairment—Estradiol—osteoporosis	4.38e-05	0.000626	CcSEcCtD
Betamethasone—Anorexia—Pamidronate—osteoporosis	4.37e-05	0.000625	CcSEcCtD
Betamethasone—Myalgia—Zoledronate—osteoporosis	4.37e-05	0.000624	CcSEcCtD
Betamethasone—Insomnia—Risedronate—osteoporosis	4.36e-05	0.000623	CcSEcCtD
Betamethasone—Anxiety—Zoledronate—osteoporosis	4.36e-05	0.000622	CcSEcCtD
Betamethasone—Loss of consciousness—Conjugated Estrogens—osteoporosis	4.34e-05	0.000621	CcSEcCtD
Betamethasone—Paraesthesia—Risedronate—osteoporosis	4.33e-05	0.000619	CcSEcCtD
Betamethasone—Pruritus—Estropipate—osteoporosis	4.32e-05	0.000617	CcSEcCtD
Betamethasone—Discomfort—Zoledronate—osteoporosis	4.32e-05	0.000617	CcSEcCtD
Betamethasone—Asthenia—Alendronate—osteoporosis	4.31e-05	0.000616	CcSEcCtD
Betamethasone—Hypotension—Pamidronate—osteoporosis	4.29e-05	0.000612	CcSEcCtD
Betamethasone—Convulsion—Conjugated Estrogens—osteoporosis	4.28e-05	0.000612	CcSEcCtD
Betamethasone—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	4.27e-05	0.00061	CcSEcCtD
Betamethasone—Fatigue—Ethinyl Estradiol—osteoporosis	4.27e-05	0.00061	CcSEcCtD
Betamethasone—Pruritus—Alendronate—osteoporosis	4.25e-05	0.000608	CcSEcCtD
Betamethasone—Dyspepsia—Risedronate—osteoporosis	4.25e-05	0.000607	CcSEcCtD
Betamethasone—Eye disorder—Estradiol—osteoporosis	4.25e-05	0.000607	CcSEcCtD
Betamethasone—Myalgia—Conjugated Estrogens—osteoporosis	4.21e-05	0.000601	CcSEcCtD
Betamethasone—Asthenia—Ibandronate—osteoporosis	4.2e-05	0.0006	CcSEcCtD
Betamethasone—Anxiety—Conjugated Estrogens—osteoporosis	4.19e-05	0.000599	CcSEcCtD
Betamethasone—Nausea—Etidronic acid—osteoporosis	4.19e-05	0.000599	CcSEcCtD
Betamethasone—Oedema—Zoledronate—osteoporosis	4.19e-05	0.000599	CcSEcCtD
Betamethasone—Anaphylactic shock—Zoledronate—osteoporosis	4.19e-05	0.000599	CcSEcCtD
Betamethasone—Musculoskeletal discomfort—Pamidronate—osteoporosis	4.18e-05	0.000597	CcSEcCtD
Betamethasone—Diarrhoea—Estropipate—osteoporosis	4.18e-05	0.000597	CcSEcCtD
Betamethasone—Gastrointestinal disorder—Risedronate—osteoporosis	4.17e-05	0.000595	CcSEcCtD
Betamethasone—Infection—Zoledronate—osteoporosis	4.16e-05	0.000595	CcSEcCtD
Betamethasone—Fatigue—Risedronate—osteoporosis	4.16e-05	0.000594	CcSEcCtD
Betamethasone—Insomnia—Pamidronate—osteoporosis	4.15e-05	0.000593	CcSEcCtD
Betamethasone—Pruritus—Ibandronate—osteoporosis	4.14e-05	0.000592	CcSEcCtD
Betamethasone—Pain—Risedronate—osteoporosis	4.13e-05	0.000589	CcSEcCtD
Betamethasone—Angiopathy—Estradiol—osteoporosis	4.12e-05	0.000589	CcSEcCtD
Betamethasone—Shock—Zoledronate—osteoporosis	4.12e-05	0.000589	CcSEcCtD
Betamethasone—Paraesthesia—Pamidronate—osteoporosis	4.12e-05	0.000588	CcSEcCtD
Betamethasone—Diarrhoea—Alendronate—osteoporosis	4.11e-05	0.000588	CcSEcCtD
Betamethasone—Asthenia—Calcitriol—osteoporosis	4.11e-05	0.000587	CcSEcCtD
Betamethasone—Nervous system disorder—Zoledronate—osteoporosis	4.11e-05	0.000587	CcSEcCtD
Betamethasone—Thrombocytopenia—Zoledronate—osteoporosis	4.1e-05	0.000586	CcSEcCtD
Betamethasone—Tachycardia—Zoledronate—osteoporosis	4.09e-05	0.000584	CcSEcCtD
Betamethasone—Feeling abnormal—Ethinyl Estradiol—osteoporosis	4.08e-05	0.000583	CcSEcCtD
Betamethasone—Pruritus—Calcitriol—osteoporosis	4.06e-05	0.000579	CcSEcCtD
Betamethasone—Hyperhidrosis—Zoledronate—osteoporosis	4.05e-05	0.000579	CcSEcCtD
Betamethasone—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	4.05e-05	0.000578	CcSEcCtD
Betamethasone—Diarrhoea—Raloxifene—osteoporosis	4.05e-05	0.000578	CcSEcCtD
Betamethasone—Dyspepsia—Pamidronate—osteoporosis	4.04e-05	0.000577	CcSEcCtD
Betamethasone—Dizziness—Estropipate—osteoporosis	4.04e-05	0.000577	CcSEcCtD
Betamethasone—Anaphylactic shock—Conjugated Estrogens—osteoporosis	4.03e-05	0.000576	CcSEcCtD
Betamethasone—Oedema—Conjugated Estrogens—osteoporosis	4.03e-05	0.000576	CcSEcCtD
Betamethasone—Alopecia—Estradiol—osteoporosis	4.02e-05	0.000574	CcSEcCtD
Betamethasone—Infection—Conjugated Estrogens—osteoporosis	4.01e-05	0.000573	CcSEcCtD
Betamethasone—Diarrhoea—Ibandronate—osteoporosis	4.01e-05	0.000572	CcSEcCtD
Betamethasone—Anorexia—Zoledronate—osteoporosis	3.99e-05	0.000571	CcSEcCtD
Betamethasone—Decreased appetite—Pamidronate—osteoporosis	3.99e-05	0.00057	CcSEcCtD
Betamethasone—Dizziness—Alendronate—osteoporosis	3.98e-05	0.000568	CcSEcCtD
Betamethasone—Shock—Conjugated Estrogens—osteoporosis	3.97e-05	0.000567	CcSEcCtD
Betamethasone—Gastrointestinal disorder—Pamidronate—osteoporosis	3.96e-05	0.000566	CcSEcCtD
Betamethasone—Nervous system disorder—Conjugated Estrogens—osteoporosis	3.96e-05	0.000565	CcSEcCtD
Betamethasone—Erythema—Estradiol—osteoporosis	3.96e-05	0.000565	CcSEcCtD
Betamethasone—Fatigue—Pamidronate—osteoporosis	3.95e-05	0.000565	CcSEcCtD
Betamethasone—Gastrointestinal pain—Risedronate—osteoporosis	3.95e-05	0.000564	CcSEcCtD
Betamethasone—Tachycardia—Conjugated Estrogens—osteoporosis	3.94e-05	0.000562	CcSEcCtD
Betamethasone—Urticaria—Ethinyl Estradiol—osteoporosis	3.93e-05	0.000562	CcSEcCtD
Betamethasone—Pain—Pamidronate—osteoporosis	3.92e-05	0.00056	CcSEcCtD
Betamethasone—Diarrhoea—Calcitriol—osteoporosis	3.92e-05	0.00056	CcSEcCtD
Betamethasone—Hypotension—Zoledronate—osteoporosis	3.92e-05	0.000559	CcSEcCtD
Betamethasone—Body temperature increased—Ethinyl Estradiol—osteoporosis	3.91e-05	0.000559	CcSEcCtD
Betamethasone—Abdominal pain—Ethinyl Estradiol—osteoporosis	3.91e-05	0.000559	CcSEcCtD
Betamethasone—Dizziness—Raloxifene—osteoporosis	3.91e-05	0.000559	CcSEcCtD
Betamethasone—Hyperhidrosis—Conjugated Estrogens—osteoporosis	3.9e-05	0.000557	CcSEcCtD
Betamethasone—Vomiting—Estropipate—osteoporosis	3.88e-05	0.000555	CcSEcCtD
Betamethasone—Dizziness—Ibandronate—osteoporosis	3.87e-05	0.000553	CcSEcCtD
Betamethasone—Rash—Estropipate—osteoporosis	3.85e-05	0.00055	CcSEcCtD
Betamethasone—Dermatitis—Estropipate—osteoporosis	3.85e-05	0.000549	CcSEcCtD
Betamethasone—Anorexia—Conjugated Estrogens—osteoporosis	3.85e-05	0.000549	CcSEcCtD
Betamethasone—Urticaria—Risedronate—osteoporosis	3.83e-05	0.000548	CcSEcCtD
Betamethasone—Headache—Estropipate—osteoporosis	3.83e-05	0.000546	CcSEcCtD
Betamethasone—Vomiting—Alendronate—osteoporosis	3.82e-05	0.000546	CcSEcCtD
Betamethasone—Musculoskeletal discomfort—Zoledronate—osteoporosis	3.82e-05	0.000545	CcSEcCtD
Betamethasone—Body temperature increased—Risedronate—osteoporosis	3.81e-05	0.000545	CcSEcCtD
Betamethasone—Abdominal pain—Risedronate—osteoporosis	3.81e-05	0.000545	CcSEcCtD
Betamethasone—Rash—Alendronate—osteoporosis	3.79e-05	0.000542	CcSEcCtD
Betamethasone—Insomnia—Zoledronate—osteoporosis	3.79e-05	0.000541	CcSEcCtD
Betamethasone—Dermatitis—Alendronate—osteoporosis	3.79e-05	0.000541	CcSEcCtD
Betamethasone—Feeling abnormal—Pamidronate—osteoporosis	3.78e-05	0.00054	CcSEcCtD
Betamethasone—Hypotension—Conjugated Estrogens—osteoporosis	3.77e-05	0.000539	CcSEcCtD
Betamethasone—Headache—Alendronate—osteoporosis	3.77e-05	0.000538	CcSEcCtD
Betamethasone—Paraesthesia—Zoledronate—osteoporosis	3.76e-05	0.000537	CcSEcCtD
Betamethasone—Vomiting—Raloxifene—osteoporosis	3.76e-05	0.000537	CcSEcCtD
Betamethasone—Gastrointestinal pain—Pamidronate—osteoporosis	3.75e-05	0.000536	CcSEcCtD
Betamethasone—Rash—Raloxifene—osteoporosis	3.73e-05	0.000533	CcSEcCtD
Betamethasone—Dermatitis—Raloxifene—osteoporosis	3.73e-05	0.000532	CcSEcCtD
Betamethasone—Vomiting—Ibandronate—osteoporosis	3.72e-05	0.000532	CcSEcCtD
Betamethasone—Headache—Raloxifene—osteoporosis	3.71e-05	0.000529	CcSEcCtD
Betamethasone—Rash—Ibandronate—osteoporosis	3.69e-05	0.000527	CcSEcCtD
Betamethasone—Dermatitis—Ibandronate—osteoporosis	3.69e-05	0.000527	CcSEcCtD
Betamethasone—Dyspepsia—Zoledronate—osteoporosis	3.69e-05	0.000527	CcSEcCtD
Betamethasone—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	3.68e-05	0.000525	CcSEcCtD
Betamethasone—Ill-defined disorder—Estradiol—osteoporosis	3.67e-05	0.000524	CcSEcCtD
Betamethasone—Headache—Ibandronate—osteoporosis	3.67e-05	0.000524	CcSEcCtD
Betamethasone—Insomnia—Conjugated Estrogens—osteoporosis	3.65e-05	0.000521	CcSEcCtD
Betamethasone—Vomiting—Calcitriol—osteoporosis	3.64e-05	0.000521	CcSEcCtD
Betamethasone—Decreased appetite—Zoledronate—osteoporosis	3.64e-05	0.00052	CcSEcCtD
Betamethasone—Nausea—Estropipate—osteoporosis	3.63e-05	0.000518	CcSEcCtD
Betamethasone—Body temperature increased—Pamidronate—osteoporosis	3.63e-05	0.000518	CcSEcCtD
Betamethasone—Abdominal pain—Pamidronate—osteoporosis	3.63e-05	0.000518	CcSEcCtD
Betamethasone—Paraesthesia—Conjugated Estrogens—osteoporosis	3.62e-05	0.000518	CcSEcCtD
Betamethasone—Gastrointestinal disorder—Zoledronate—osteoporosis	3.62e-05	0.000517	CcSEcCtD
Betamethasone—Angioedema—Estradiol—osteoporosis	3.62e-05	0.000516	CcSEcCtD
Betamethasone—Rash—Calcitriol—osteoporosis	3.61e-05	0.000516	CcSEcCtD
Betamethasone—Fatigue—Zoledronate—osteoporosis	3.61e-05	0.000516	CcSEcCtD
Betamethasone—Dermatitis—Calcitriol—osteoporosis	3.61e-05	0.000516	CcSEcCtD
Betamethasone—Headache—Calcitriol—osteoporosis	3.59e-05	0.000513	CcSEcCtD
Betamethasone—Pain—Zoledronate—osteoporosis	3.58e-05	0.000512	CcSEcCtD
Betamethasone—Nausea—Alendronate—osteoporosis	3.57e-05	0.00051	CcSEcCtD
Betamethasone—Malaise—Estradiol—osteoporosis	3.57e-05	0.00051	CcSEcCtD
Betamethasone—Vertigo—Estradiol—osteoporosis	3.55e-05	0.000508	CcSEcCtD
Betamethasone—Dyspepsia—Conjugated Estrogens—osteoporosis	3.55e-05	0.000507	CcSEcCtD
Betamethasone—Asthenia—Ethinyl Estradiol—osteoporosis	3.55e-05	0.000507	CcSEcCtD
Betamethasone—Syncope—Estradiol—osteoporosis	3.55e-05	0.000507	CcSEcCtD
Betamethasone—Nausea—Raloxifene—osteoporosis	3.51e-05	0.000502	CcSEcCtD
Betamethasone—Decreased appetite—Conjugated Estrogens—osteoporosis	3.51e-05	0.000501	CcSEcCtD
Betamethasone—Pruritus—Ethinyl Estradiol—osteoporosis	3.5e-05	0.0005	CcSEcCtD
Betamethasone—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	3.48e-05	0.000498	CcSEcCtD
Betamethasone—Fatigue—Conjugated Estrogens—osteoporosis	3.48e-05	0.000497	CcSEcCtD
Betamethasone—Nausea—Ibandronate—osteoporosis	3.48e-05	0.000497	CcSEcCtD
Betamethasone—Loss of consciousness—Estradiol—osteoporosis	3.48e-05	0.000497	CcSEcCtD
Betamethasone—Asthenia—Risedronate—osteoporosis	3.46e-05	0.000495	CcSEcCtD
Betamethasone—Feeling abnormal—Zoledronate—osteoporosis	3.45e-05	0.000493	CcSEcCtD
Betamethasone—Pain—Conjugated Estrogens—osteoporosis	3.45e-05	0.000493	CcSEcCtD
Betamethasone—Gastrointestinal pain—Zoledronate—osteoporosis	3.43e-05	0.000489	CcSEcCtD
Betamethasone—Hypertension—Estradiol—osteoporosis	3.42e-05	0.000488	CcSEcCtD
Betamethasone—Pruritus—Risedronate—osteoporosis	3.41e-05	0.000488	CcSEcCtD
Betamethasone—Nausea—Calcitriol—osteoporosis	3.4e-05	0.000486	CcSEcCtD
Betamethasone—Diarrhoea—Ethinyl Estradiol—osteoporosis	3.39e-05	0.000484	CcSEcCtD
Betamethasone—Myalgia—Estradiol—osteoporosis	3.37e-05	0.000481	CcSEcCtD
Betamethasone—Anxiety—Estradiol—osteoporosis	3.36e-05	0.00048	CcSEcCtD
Betamethasone—Urticaria—Zoledronate—osteoporosis	3.33e-05	0.000476	CcSEcCtD
Betamethasone—Discomfort—Estradiol—osteoporosis	3.33e-05	0.000475	CcSEcCtD
Betamethasone—Abdominal pain—Zoledronate—osteoporosis	3.31e-05	0.000473	CcSEcCtD
Betamethasone—Body temperature increased—Zoledronate—osteoporosis	3.31e-05	0.000473	CcSEcCtD
Betamethasone—Diarrhoea—Risedronate—osteoporosis	3.3e-05	0.000472	CcSEcCtD
Betamethasone—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	3.3e-05	0.000471	CcSEcCtD
Betamethasone—Asthenia—Pamidronate—osteoporosis	3.29e-05	0.00047	CcSEcCtD
Betamethasone—Dizziness—Ethinyl Estradiol—osteoporosis	3.27e-05	0.000468	CcSEcCtD
Betamethasone—Pruritus—Pamidronate—osteoporosis	3.25e-05	0.000464	CcSEcCtD
Betamethasone—Anaphylactic shock—Estradiol—osteoporosis	3.23e-05	0.000461	CcSEcCtD
Betamethasone—Oedema—Estradiol—osteoporosis	3.23e-05	0.000461	CcSEcCtD
Betamethasone—Infection—Estradiol—osteoporosis	3.21e-05	0.000458	CcSEcCtD
Betamethasone—Urticaria—Conjugated Estrogens—osteoporosis	3.21e-05	0.000458	CcSEcCtD
Betamethasone—Dizziness—Risedronate—osteoporosis	3.19e-05	0.000456	CcSEcCtD
Betamethasone—Body temperature increased—Conjugated Estrogens—osteoporosis	3.19e-05	0.000456	CcSEcCtD
Betamethasone—Abdominal pain—Conjugated Estrogens—osteoporosis	3.19e-05	0.000456	CcSEcCtD
Betamethasone—Shock—Estradiol—osteoporosis	3.18e-05	0.000454	CcSEcCtD
Betamethasone—Nervous system disorder—Estradiol—osteoporosis	3.17e-05	0.000452	CcSEcCtD
Betamethasone—Tachycardia—Estradiol—osteoporosis	3.15e-05	0.00045	CcSEcCtD
Betamethasone—Vomiting—Ethinyl Estradiol—osteoporosis	3.15e-05	0.00045	CcSEcCtD
Betamethasone—Diarrhoea—Pamidronate—osteoporosis	3.14e-05	0.000448	CcSEcCtD
Betamethasone—Hyperhidrosis—Estradiol—osteoporosis	3.12e-05	0.000446	CcSEcCtD
Betamethasone—Rash—Ethinyl Estradiol—osteoporosis	3.12e-05	0.000446	CcSEcCtD
Betamethasone—Dermatitis—Ethinyl Estradiol—osteoporosis	3.12e-05	0.000445	CcSEcCtD
Betamethasone—Headache—Ethinyl Estradiol—osteoporosis	3.1e-05	0.000443	CcSEcCtD
Betamethasone—Vomiting—Risedronate—osteoporosis	3.07e-05	0.000438	CcSEcCtD
Betamethasone—Rash—Risedronate—osteoporosis	3.04e-05	0.000435	CcSEcCtD
Betamethasone—Dermatitis—Risedronate—osteoporosis	3.04e-05	0.000434	CcSEcCtD
Betamethasone—Dizziness—Pamidronate—osteoporosis	3.03e-05	0.000433	CcSEcCtD
Betamethasone—Headache—Risedronate—osteoporosis	3.02e-05	0.000432	CcSEcCtD
Betamethasone—Asthenia—Zoledronate—osteoporosis	3.01e-05	0.000429	CcSEcCtD
Betamethasone—Pruritus—Zoledronate—osteoporosis	2.96e-05	0.000423	CcSEcCtD
Betamethasone—Musculoskeletal discomfort—Estradiol—osteoporosis	2.94e-05	0.00042	CcSEcCtD
Betamethasone—Nausea—Ethinyl Estradiol—osteoporosis	2.94e-05	0.00042	CcSEcCtD
Betamethasone—Insomnia—Estradiol—osteoporosis	2.92e-05	0.000417	CcSEcCtD
Betamethasone—Vomiting—Pamidronate—osteoporosis	2.92e-05	0.000417	CcSEcCtD
Betamethasone—Paraesthesia—Estradiol—osteoporosis	2.9e-05	0.000414	CcSEcCtD
Betamethasone—Asthenia—Conjugated Estrogens—osteoporosis	2.89e-05	0.000414	CcSEcCtD
Betamethasone—Rash—Pamidronate—osteoporosis	2.89e-05	0.000413	CcSEcCtD
Betamethasone—Dermatitis—Pamidronate—osteoporosis	2.89e-05	0.000413	CcSEcCtD
Betamethasone—Headache—Pamidronate—osteoporosis	2.87e-05	0.000411	CcSEcCtD
Betamethasone—Diarrhoea—Zoledronate—osteoporosis	2.87e-05	0.00041	CcSEcCtD
Betamethasone—Nausea—Risedronate—osteoporosis	2.87e-05	0.000409	CcSEcCtD
Betamethasone—Pruritus—Conjugated Estrogens—osteoporosis	2.85e-05	0.000408	CcSEcCtD
Betamethasone—Dyspepsia—Estradiol—osteoporosis	2.84e-05	0.000406	CcSEcCtD
Betamethasone—Decreased appetite—Estradiol—osteoporosis	2.81e-05	0.000401	CcSEcCtD
Betamethasone—Gastrointestinal disorder—Estradiol—osteoporosis	2.79e-05	0.000398	CcSEcCtD
Betamethasone—Fatigue—Estradiol—osteoporosis	2.78e-05	0.000398	CcSEcCtD
Betamethasone—Dizziness—Zoledronate—osteoporosis	2.77e-05	0.000396	CcSEcCtD
Betamethasone—Pain—Estradiol—osteoporosis	2.76e-05	0.000394	CcSEcCtD
Betamethasone—Diarrhoea—Conjugated Estrogens—osteoporosis	2.76e-05	0.000394	CcSEcCtD
Betamethasone—Nausea—Pamidronate—osteoporosis	2.72e-05	0.000389	CcSEcCtD
Betamethasone—Dizziness—Conjugated Estrogens—osteoporosis	2.67e-05	0.000381	CcSEcCtD
Betamethasone—Vomiting—Zoledronate—osteoporosis	2.66e-05	0.000381	CcSEcCtD
Betamethasone—Feeling abnormal—Estradiol—osteoporosis	2.66e-05	0.00038	CcSEcCtD
Betamethasone—Rash—Zoledronate—osteoporosis	2.64e-05	0.000377	CcSEcCtD
Betamethasone—Gastrointestinal pain—Estradiol—osteoporosis	2.64e-05	0.000377	CcSEcCtD
Betamethasone—Dermatitis—Zoledronate—osteoporosis	2.64e-05	0.000377	CcSEcCtD
Betamethasone—Headache—Zoledronate—osteoporosis	2.62e-05	0.000375	CcSEcCtD
Betamethasone—Vomiting—Conjugated Estrogens—osteoporosis	2.57e-05	0.000366	CcSEcCtD
Betamethasone—Urticaria—Estradiol—osteoporosis	2.57e-05	0.000366	CcSEcCtD
Betamethasone—Body temperature increased—Estradiol—osteoporosis	2.55e-05	0.000365	CcSEcCtD
Betamethasone—Abdominal pain—Estradiol—osteoporosis	2.55e-05	0.000365	CcSEcCtD
Betamethasone—Rash—Conjugated Estrogens—osteoporosis	2.54e-05	0.000363	CcSEcCtD
Betamethasone—Dermatitis—Conjugated Estrogens—osteoporosis	2.54e-05	0.000363	CcSEcCtD
Betamethasone—Headache—Conjugated Estrogens—osteoporosis	2.53e-05	0.000361	CcSEcCtD
Betamethasone—NR3C1—AP-1 transcription factor network—TGFB1—osteoporosis	2.52e-05	0.00122	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	2.52e-05	0.00122	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	2.49e-05	0.00121	CbGpPWpGaD
Betamethasone—PTGS2—Aryl Hydrocarbon Receptor—TNF—osteoporosis	2.49e-05	0.00121	CbGpPWpGaD
Betamethasone—Nausea—Zoledronate—osteoporosis	2.49e-05	0.000356	CcSEcCtD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	2.45e-05	0.00119	CbGpPWpGaD
Betamethasone—PGR—Generic Transcription Pathway—VDR—osteoporosis	2.44e-05	0.00119	CbGpPWpGaD
Betamethasone—NR3C2—Gene Expression—ESR2—osteoporosis	2.43e-05	0.00118	CbGpPWpGaD
Betamethasone—CYP19A1—Biological oxidations—POMC—osteoporosis	2.41e-05	0.00117	CbGpPWpGaD
Betamethasone—Nausea—Conjugated Estrogens—osteoporosis	2.4e-05	0.000342	CcSEcCtD
Betamethasone—PLA2G1B—Metabolism—ENO1—osteoporosis	2.35e-05	0.00114	CbGpPWpGaD
Betamethasone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—osteoporosis	2.33e-05	0.00113	CbGpPWpGaD
Betamethasone—Asthenia—Estradiol—osteoporosis	2.32e-05	0.000331	CcSEcCtD
Betamethasone—PLA2G1B—Metabolism—PSMA5—osteoporosis	2.32e-05	0.00113	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—PSMA2—osteoporosis	2.32e-05	0.00113	CbGpPWpGaD
Betamethasone—Pruritus—Estradiol—osteoporosis	2.28e-05	0.000326	CcSEcCtD
Betamethasone—CYP19A1—Metabolism—FDPS—osteoporosis	2.27e-05	0.00111	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—PKM—osteoporosis	2.27e-05	0.00111	CbGpPWpGaD
Betamethasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—osteoporosis	2.24e-05	0.00109	CbGpPWpGaD
Betamethasone—NR3C1—SIDS Susceptibility Pathways—IL6R—osteoporosis	2.24e-05	0.00109	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—U2AF1—osteoporosis	2.24e-05	0.00109	CbGpPWpGaD
Betamethasone—CYP3A4—Biological oxidations—CYP27A1—osteoporosis	2.23e-05	0.00108	CbGpPWpGaD
Betamethasone—Diarrhoea—Estradiol—osteoporosis	2.21e-05	0.000316	CcSEcCtD
Betamethasone—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	2.2e-05	0.00107	CbGpPWpGaD
Betamethasone—CYP3A4—Metapathway biotransformation—CYP27A1—osteoporosis	2.2e-05	0.00107	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—PGLS—osteoporosis	2.16e-05	0.00105	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—GPD2—osteoporosis	2.16e-05	0.00105	CbGpPWpGaD
Betamethasone—Dizziness—Estradiol—osteoporosis	2.14e-05	0.000305	CcSEcCtD
Betamethasone—PGR—Signaling Pathways—MGLL—osteoporosis	2.08e-05	0.00101	CbGpPWpGaD
Betamethasone—Vomiting—Estradiol—osteoporosis	2.05e-05	0.000293	CcSEcCtD
Betamethasone—PTGS2—Selenium Micronutrient Network—IL1B—osteoporosis	2.04e-05	0.000995	CbGpPWpGaD
Betamethasone—Rash—Estradiol—osteoporosis	2.04e-05	0.000291	CcSEcCtD
Betamethasone—Dermatitis—Estradiol—osteoporosis	2.03e-05	0.000291	CcSEcCtD
Betamethasone—PGR—Signaling Pathways—LRP5—osteoporosis	2.03e-05	0.00099	CbGpPWpGaD
Betamethasone—Headache—Estradiol—osteoporosis	2.02e-05	0.000289	CcSEcCtD
Betamethasone—CYP19A1—Metabolism—ATIC—osteoporosis	1.97e-05	0.00096	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—PNP—osteoporosis	1.97e-05	0.00096	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	1.96e-05	0.000954	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—LRP6—osteoporosis	1.95e-05	0.000947	CbGpPWpGaD
Betamethasone—NR3C2—Gene Expression—VDR—osteoporosis	1.93e-05	0.00094	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—osteoporosis	1.92e-05	0.000937	CbGpPWpGaD
Betamethasone—Nausea—Estradiol—osteoporosis	1.92e-05	0.000274	CcSEcCtD
Betamethasone—NR3C1—AP-1 transcription factor network—IL6—osteoporosis	1.9e-05	0.000923	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—CYP19A1—osteoporosis	1.88e-05	0.000914	CbGpPWpGaD
Betamethasone—PGR—Generic Transcription Pathway—ESR1—osteoporosis	1.87e-05	0.000909	CbGpPWpGaD
Betamethasone—PTGS2—Disease—PKM—osteoporosis	1.81e-05	0.000883	CbGpPWpGaD
Betamethasone—PTGS2—Disease—SOST—osteoporosis	1.81e-05	0.000883	CbGpPWpGaD
Betamethasone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—osteoporosis	1.8e-05	0.000877	CbGpPWpGaD
Betamethasone—NR3C1—Generic Transcription Pathway—ESR2—osteoporosis	1.78e-05	0.000866	CbGpPWpGaD
Betamethasone—PGR—Signaling by ERBB4—IL6—osteoporosis	1.76e-05	0.000859	CbGpPWpGaD
Betamethasone—PTGS2—Disease—ANTXR2—osteoporosis	1.72e-05	0.000837	CbGpPWpGaD
Betamethasone—PTGS2—Disease—PGLS—osteoporosis	1.72e-05	0.000837	CbGpPWpGaD
Betamethasone—NR3C1—SIDS Susceptibility Pathways—IL1B—osteoporosis	1.71e-05	0.00083	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—CA2—osteoporosis	1.68e-05	0.000816	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—OXCT1—osteoporosis	1.68e-05	0.000816	CbGpPWpGaD
Betamethasone—NR3C1—Glucocorticoid receptor regulatory network—IL6—osteoporosis	1.67e-05	0.000813	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	1.67e-05	0.000811	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—RPL24—osteoporosis	1.66e-05	0.000809	CbGpPWpGaD
Betamethasone—PGR—Gene Expression—PSMA5—osteoporosis	1.66e-05	0.000807	CbGpPWpGaD
Betamethasone—PGR—Gene Expression—PSMA2—osteoporosis	1.66e-05	0.000807	CbGpPWpGaD
Betamethasone—PTGS2—C-MYB transcription factor network—MYC—osteoporosis	1.65e-05	0.000804	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—ESR1—osteoporosis	1.65e-05	0.000801	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—TLN1—osteoporosis	1.64e-05	0.0008	CbGpPWpGaD
Betamethasone—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	1.63e-05	0.000795	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—MGLL—osteoporosis	1.63e-05	0.000795	CbGpPWpGaD
Betamethasone—PTGS2—Spinal Cord Injury—IL1B—osteoporosis	1.62e-05	0.000787	CbGpPWpGaD
Betamethasone—NR3C2—Generic Transcription Pathway—MYC—osteoporosis	1.59e-05	0.000776	CbGpPWpGaD
Betamethasone—ABCB1—Allograft Rejection—IL1B—osteoporosis	1.58e-05	0.000769	CbGpPWpGaD
Betamethasone—CYP19A1—Integrated Breast Cancer Pathway—MYC—osteoporosis	1.55e-05	0.000753	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—ADCY5—osteoporosis	1.53e-05	0.000747	CbGpPWpGaD
Betamethasone—NR3C1—Adipogenesis—TGFB1—osteoporosis	1.53e-05	0.000746	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—GPX1—osteoporosis	1.53e-05	0.000745	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—FDPS—osteoporosis	1.52e-05	0.00074	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—PKM—osteoporosis	1.52e-05	0.00074	CbGpPWpGaD
Betamethasone—ABCB1—Transmembrane transport of small molecules—ANXA2—osteoporosis	1.51e-05	0.000735	CbGpPWpGaD
Betamethasone—PTGS2—Selenium Micronutrient Network—TNF—osteoporosis	1.48e-05	0.000722	CbGpPWpGaD
Betamethasone—PGR—Gene Expression—ESR2—osteoporosis	1.48e-05	0.000721	CbGpPWpGaD
Betamethasone—NR3C2—Gene Expression—ESR1—osteoporosis	1.48e-05	0.000718	CbGpPWpGaD
Betamethasone—PTGS2—Disease—GSN—osteoporosis	1.46e-05	0.000712	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—PGLS—osteoporosis	1.44e-05	0.000701	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—GPD2—osteoporosis	1.44e-05	0.000701	CbGpPWpGaD
Betamethasone—NR3C1—Adipogenesis—TNF—osteoporosis	1.43e-05	0.000697	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—IGF1—osteoporosis	1.42e-05	0.000694	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—P4HB—osteoporosis	1.42e-05	0.000689	CbGpPWpGaD
Betamethasone—NR3C1—Generic Transcription Pathway—VDR—osteoporosis	1.41e-05	0.000687	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—MTHFR—osteoporosis	1.41e-05	0.000687	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—IDH2—osteoporosis	1.39e-05	0.000676	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—PTH—osteoporosis	1.38e-05	0.000671	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—RAP1A—osteoporosis	1.35e-05	0.000659	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—CNR2—osteoporosis	1.34e-05	0.000654	CbGpPWpGaD
Betamethasone—CYP3A4—Phase 1 - Functionalization of compounds—POMC—osteoporosis	1.32e-05	0.000645	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—NFATC1—osteoporosis	1.32e-05	0.000643	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—PNP—osteoporosis	1.32e-05	0.000641	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—ATIC—osteoporosis	1.32e-05	0.000641	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—DKK1—osteoporosis	1.31e-05	0.000638	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—CYP27A1—osteoporosis	1.31e-05	0.000636	CbGpPWpGaD
Betamethasone—PTGS2—Disease—LRP5—osteoporosis	1.27e-05	0.000619	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—ACP5—osteoporosis	1.27e-05	0.000618	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—WNT1—osteoporosis	1.26e-05	0.000614	CbGpPWpGaD
Betamethasone—PTGS2—Spinal Cord Injury—MYC—osteoporosis	1.26e-05	0.000613	CbGpPWpGaD
Betamethasone—PTGS2—Spinal Cord Injury—TGFB1—osteoporosis	1.26e-05	0.000611	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	1.25e-05	0.000611	CbGpPWpGaD
Betamethasone—NR3C1—SIDS Susceptibility Pathways—TNF—osteoporosis	1.24e-05	0.000602	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—FGA—osteoporosis	1.23e-05	0.000598	CbGpPWpGaD
Betamethasone—ABCB1—Allograft Rejection—TGFB1—osteoporosis	1.23e-05	0.000597	CbGpPWpGaD
Betamethasone—PTGS2—Disease—LRP6—osteoporosis	1.22e-05	0.000592	CbGpPWpGaD
Betamethasone—PTGS2—Selenium Micronutrient Network—IL6—osteoporosis	1.2e-05	0.000582	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—TPI1—osteoporosis	1.18e-05	0.000575	CbGpPWpGaD
Betamethasone—PGR—Gene Expression—VDR—osteoporosis	1.18e-05	0.000573	CbGpPWpGaD
Betamethasone—PTGS2—Spinal Cord Injury—TNF—osteoporosis	1.17e-05	0.000571	CbGpPWpGaD
Betamethasone—CYP3A4—Biological oxidations—CYP19A1—osteoporosis	1.17e-05	0.00057	CbGpPWpGaD
Betamethasone—PTGS2—Disease—RPL24—osteoporosis	1.17e-05	0.000569	CbGpPWpGaD
Betamethasone—PTGS2—Disease—LTF—osteoporosis	1.17e-05	0.000569	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—osteoporosis	1.17e-05	0.000568	CbGpPWpGaD
Betamethasone—NR3C1—Adipogenesis—IL6—osteoporosis	1.16e-05	0.000562	CbGpPWpGaD
Betamethasone—CYP3A4—Metapathway biotransformation—CYP19A1—osteoporosis	1.15e-05	0.000562	CbGpPWpGaD
Betamethasone—ABCB1—Allograft Rejection—TNF—osteoporosis	1.15e-05	0.000558	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—BMP2—osteoporosis	1.14e-05	0.000556	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—PTHLH—osteoporosis	1.14e-05	0.000556	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—POMC—osteoporosis	1.13e-05	0.00055	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—OXCT1—osteoporosis	1.12e-05	0.000545	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—CA2—osteoporosis	1.12e-05	0.000545	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—FGB—osteoporosis	1.12e-05	0.000544	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—P4HB—osteoporosis	1.11e-05	0.000541	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—MGLL—osteoporosis	1.09e-05	0.000531	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—GAPDH—osteoporosis	1.09e-05	0.000531	CbGpPWpGaD
Betamethasone—NR3C1—Generic Transcription Pathway—ESR1—osteoporosis	1.08e-05	0.000525	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—PSMA5—osteoporosis	1.08e-05	0.000525	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—PSMA2—osteoporosis	1.08e-05	0.000525	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—FDPS—osteoporosis	1.08e-05	0.000524	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—PKM—osteoporosis	1.08e-05	0.000524	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—RAP1A—osteoporosis	1.06e-05	0.000517	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	1.03e-05	0.000501	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—GPD2—osteoporosis	1.02e-05	0.000497	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—PGLS—osteoporosis	1.02e-05	0.000497	CbGpPWpGaD
Betamethasone—PTGS2—Disease—ACP5—osteoporosis	1.01e-05	0.000493	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—osteoporosis	1.01e-05	0.000492	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—CALCA—osteoporosis	1.01e-05	0.000489	CbGpPWpGaD
Betamethasone—NR3C1—SIDS Susceptibility Pathways—IL6—osteoporosis	9.99e-06	0.000486	CbGpPWpGaD
Betamethasone—PGR—Generic Transcription Pathway—MYC—osteoporosis	9.71e-06	0.000473	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—PSMA5—osteoporosis	9.59e-06	0.000467	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—PSMA2—osteoporosis	9.59e-06	0.000467	CbGpPWpGaD
Betamethasone—PTGS2—Spinal Cord Injury—IL6—osteoporosis	9.46e-06	0.000461	CbGpPWpGaD
Betamethasone—PTGS2—Disease—TPI1—osteoporosis	9.42e-06	0.000459	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—PNP—osteoporosis	9.34e-06	0.000455	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—ATIC—osteoporosis	9.34e-06	0.000455	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—IDH2—osteoporosis	9.28e-06	0.000452	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism of lipids and lipoproteins—POMC—osteoporosis	9.26e-06	0.000451	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—KL—osteoporosis	9.13e-06	0.000444	CbGpPWpGaD
Betamethasone—PGR—Gene Expression—ESR1—osteoporosis	8.99e-06	0.000438	CbGpPWpGaD
Betamethasone—PTGS2—Disease—P4HB—osteoporosis	8.86e-06	0.000431	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—CYP27A1—osteoporosis	8.73e-06	0.000425	CbGpPWpGaD
Betamethasone—PTGS2—Disease—GAPDH—osteoporosis	8.7e-06	0.000423	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—ENO1—osteoporosis	8.58e-06	0.000418	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—ESR2—osteoporosis	8.57e-06	0.000417	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	8.56e-06	0.000417	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	8.54e-06	0.000416	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—ACP5—osteoporosis	8.49e-06	0.000413	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—PSMA2—osteoporosis	8.46e-06	0.000412	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—PSMA5—osteoporosis	8.46e-06	0.000412	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	8.38e-06	0.000408	CbGpPWpGaD
Betamethasone—PTGS2—Disease—NFATC1—osteoporosis	8.26e-06	0.000402	CbGpPWpGaD
Betamethasone—PTGS2—Disease—DKK1—osteoporosis	8.2e-06	0.000399	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	7.98e-06	0.000388	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—CA2—osteoporosis	7.94e-06	0.000386	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—OXCT1—osteoporosis	7.94e-06	0.000386	CbGpPWpGaD
Betamethasone—PTGS2—Disease—WNT1—osteoporosis	7.9e-06	0.000384	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—TPI1—osteoporosis	7.89e-06	0.000384	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—MGLL—osteoporosis	7.74e-06	0.000377	CbGpPWpGaD
Betamethasone—PTGS2—Disease—FGA—osteoporosis	7.68e-06	0.000374	CbGpPWpGaD
Betamethasone—NR3C2—Gene Expression—MYC—osteoporosis	7.68e-06	0.000374	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—P4HB—osteoporosis	7.42e-06	0.000361	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—GAPDH—osteoporosis	7.28e-06	0.000355	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—ADCY5—osteoporosis	7.15e-06	0.000348	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—RAP1A—osteoporosis	7.09e-06	0.000345	CbGpPWpGaD
Betamethasone—CYP3A4—Biological oxidations—POMC—osteoporosis	7.04e-06	0.000342	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—SPP1—osteoporosis	6.92e-06	0.000337	CbGpPWpGaD
Betamethasone—PTGS2—Disease—ENO1—osteoporosis	6.85e-06	0.000333	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—VDR—osteoporosis	6.8e-06	0.000331	CbGpPWpGaD
Betamethasone—PTGS2—Disease—PSMA2—osteoporosis	6.75e-06	0.000328	CbGpPWpGaD
Betamethasone—PTGS2—Disease—PSMA5—osteoporosis	6.75e-06	0.000328	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—PKM—osteoporosis	6.64e-06	0.000323	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—FDPS—osteoporosis	6.64e-06	0.000323	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—IDH2—osteoporosis	6.58e-06	0.00032	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—GPD2—osteoporosis	6.29e-06	0.000306	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—PGLS—osteoporosis	6.29e-06	0.000306	CbGpPWpGaD
Betamethasone—PTGS2—Disease—CALCA—osteoporosis	6.29e-06	0.000306	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—IRS2—osteoporosis	6.26e-06	0.000304	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—POMC—osteoporosis	6.19e-06	0.000301	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—CYP27A1—osteoporosis	6.19e-06	0.000301	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—LEP—osteoporosis	6.12e-06	0.000298	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	6.07e-06	0.000295	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	6.06e-06	0.000295	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—ACP5—osteoporosis	6.02e-06	0.000293	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—ESR1—osteoporosis	5.84e-06	0.000284	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—PNP—osteoporosis	5.75e-06	0.00028	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—ATIC—osteoporosis	5.75e-06	0.00028	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—ENO1—osteoporosis	5.73e-06	0.000279	CbGpPWpGaD
Betamethasone—PTGS2—Disease—KL—osteoporosis	5.71e-06	0.000278	CbGpPWpGaD
Betamethasone—ABCB1—Transmembrane transport of small molecules—ADCY5—osteoporosis	5.67e-06	0.000276	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	5.65e-06	0.000275	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—PSMA2—osteoporosis	5.65e-06	0.000275	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—PSMA5—osteoporosis	5.65e-06	0.000275	CbGpPWpGaD
Betamethasone—NR3C1—Generic Transcription Pathway—MYC—osteoporosis	5.61e-06	0.000273	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—ADCY5—osteoporosis	5.61e-06	0.000273	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—TPI1—osteoporosis	5.59e-06	0.000272	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—GPX1—osteoporosis	5.59e-06	0.000272	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—IRS1—osteoporosis	5.46e-06	0.000266	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—P4HB—osteoporosis	5.26e-06	0.000256	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—POMC—osteoporosis	5.26e-06	0.000256	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—ESR1—osteoporosis	5.2e-06	0.000253	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—GAPDH—osteoporosis	5.16e-06	0.000251	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—MTHFR—osteoporosis	5.16e-06	0.000251	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—IL6R—osteoporosis	5.13e-06	0.00025	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—IGF1—osteoporosis	5.06e-06	0.000246	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—RAP1A—osteoporosis	5.03e-06	0.000245	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—CA2—osteoporosis	4.89e-06	0.000238	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—OXCT1—osteoporosis	4.89e-06	0.000238	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—MGLL—osteoporosis	4.77e-06	0.000232	CbGpPWpGaD
Betamethasone—PGR—Gene Expression—MYC—osteoporosis	4.68e-06	0.000228	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—CYP19A1—osteoporosis	4.58e-06	0.000223	CbGpPWpGaD
Betamethasone—PTGS2—Disease—ADCY5—osteoporosis	4.47e-06	0.000218	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—POMC—osteoporosis	4.12e-06	0.000201	CbGpPWpGaD
Betamethasone—PTGS2—Disease—MTHFR—osteoporosis	4.11e-06	0.0002	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—ENO1—osteoporosis	4.06e-06	0.000198	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—IDH2—osteoporosis	4.05e-06	0.000197	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—PSMA5—osteoporosis	4.01e-06	0.000195	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—PSMA2—osteoporosis	4.01e-06	0.000195	CbGpPWpGaD
Betamethasone—PTGS2—Disease—IRS2—osteoporosis	3.91e-06	0.00019	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—CYP27A1—osteoporosis	3.81e-06	0.000186	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—ADCY5—osteoporosis	3.75e-06	0.000182	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—GPX1—osteoporosis	3.73e-06	0.000182	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—ACP5—osteoporosis	3.71e-06	0.00018	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—TPI1—osteoporosis	3.45e-06	0.000168	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—MTHFR—osteoporosis	3.44e-06	0.000168	CbGpPWpGaD
Betamethasone—PTGS2—Disease—IRS1—osteoporosis	3.42e-06	0.000166	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—CYP19A1—osteoporosis	3.25e-06	0.000158	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—P4HB—osteoporosis	3.24e-06	0.000158	CbGpPWpGaD
Betamethasone—PTGS2—Disease—IL6R—osteoporosis	3.21e-06	0.000156	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—GAPDH—osteoporosis	3.18e-06	0.000155	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—RAP1A—osteoporosis	3.1e-06	0.000151	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—MYC—osteoporosis	3.04e-06	0.000148	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—TGFB1—osteoporosis	3.03e-06	0.000148	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—POMC—osteoporosis	2.75e-06	0.000134	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—MYC—osteoporosis	2.7e-06	0.000132	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—ADCY5—osteoporosis	2.65e-06	0.000129	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—GPX1—osteoporosis	2.65e-06	0.000129	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—ENO1—osteoporosis	2.5e-06	0.000122	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—PSMA2—osteoporosis	2.47e-06	0.00012	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—PSMA5—osteoporosis	2.47e-06	0.00012	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—MTHFR—osteoporosis	2.44e-06	0.000119	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—IL6—osteoporosis	2.29e-06	0.000111	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—CYP19A1—osteoporosis	2e-06	9.75e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—POMC—osteoporosis	1.95e-06	9.51e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—MYC—osteoporosis	1.9e-06	9.26e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—TGFB1—osteoporosis	1.9e-06	9.23e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—ADCY5—osteoporosis	1.64e-06	7.96e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—GPX1—osteoporosis	1.63e-06	7.94e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—MTHFR—osteoporosis	1.5e-06	7.32e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—IL6—osteoporosis	1.43e-06	6.96e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—POMC—osteoporosis	1.2e-06	5.86e-05	CbGpPWpGaD
